| 纳洛酮治疗肝性脑病 |
| |
| 引用本文： | 陈德容,卢淑玲,蔡任军. 纳洛酮治疗肝性脑病[J]. 国际医药卫生导报, 2004, 10(14): 144-145 |
| |
| 作者姓名： | 陈德容 卢淑玲 蔡任军 |
| |
| 作者单位： | 1. 东莞市长安医院内科,广东,东莞,523843
2. 东莞市人民医院,广东,东莞,523000 |
| |
| 摘 要： | 目的观察纳洛酮治疗肝硬化合并肝性脑病的疗效。方法肝硬化合并肝性脑病89例,随机分成2组,治疗组45例,对照组44例;对照组给予常规治疗,治疗组在常规治疗的基础上,加用纳洛酮,治疗前后测定血氨和血浆内啡肽(β-EP)水平。结果治疗组显效26例,有效11例,总有效率为82.2%;对照组显效13例,有效14例,总有效率为61.4%,两组在显效例数以及总有效率有显著性差异(p<0.05);两组病人治疗后血氨均明显下降,治疗后两组血氨比较,无显著性差异(P>0.05);两组病人治疗后血浆β-EP均下降,但治疗组下降更显著(P<0.05)。结论纳洛酮治疗肝硬化并发肝性脑病疗效确切。
|
| 关 键 词： | 肝硬化 肝性脑病 纳洛酮 |
| 文章编号： | 1007-1245(2004)14-0144-02 |
| 修稿时间： | 2004-04-15 |
Clinical Research of Naloxone on Cirrhotic Patients with Hepatic Encephalopathy |
| |
| Abstract: | Objective To observe the clinical effects of naloxone on cirrhotic patients withhepatic encephalopathe [ HE] .Method Eighty-night cases of cirrhotic patients with HE were randomlydivided into two groups.The patients of control group(44 cases)just received routine treatment. Intreatment group , the patient were added naloxone at the base of routine treatment. Ammonia and endorphinin plasm were detected pre -and post-treatment. Result There was significant difference in theexcellent effective rate and the total effective rate between the two groups( P< 0.05) .Blood ammoniadecreased significantly in two groups after treatment of naloxone without difference between the twogroups. Compared with control group, endotphin in plasm was lower after treayment.Conclusion Nalox-one is effective in the treatment of HE. |
| |
| Keywords: | Hepatic cirrhosis Naloxone Encephalopathy Hepatic |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
